机器学习和代谢学识别了与性结肠炎疾病程度相关的生物标志物
Changchang Ge1, Yi Lu1, Zhaofeng Shen1
1Department of Gastroenterology, Jiangsu Provincial Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Journal of Crohn's & colitis
|February 4, 2025
概括
血清代谢分析确定了性结肠炎 (UC) 疾病程度的关键生物标志物. 这些发现有助于预测UC的进展,并为这种慢性肠道炎症疾病的治疗决策提供指导.
科学领域:
- 胃肠病学 胃肠病学
- 代谢学 代谢学 代谢学
- 生物标志物发现发现
背景情况:
- 性结肠炎 (UC) 是一种由新陈代谢影响的慢性肠道炎症疾病.
- 疾病的程度是管理UC的关键因素.
- 治疗决策和风险分层需要UC程度的非侵入性生物标志物.
研究的目的:
- 确定非侵入性血清代谢生物标志物,以确定性结肠炎疾病的程度.
- 利用机器学习进行代谢物查和预测模型构建.
主要方法:
- 坐标部分最小方程差异分析 (OPLS-DA) 用于代谢物识别.
- 机器学习算法包括LASSO,RF-RFE和SVM-RFE用于代谢物选.
- 五个机器学习模型 (XGBoost,KNN,Naive Bayes,RF,SVM) 用于预测.
主要成果:
- 在UC患者和健康对照者之间发现了220种不同的代谢物.
- 选了8种基本代谢物,以区分UC患者和HC患者.
- 与UC疾病程度相关的特定代谢物变化 (三酸,酸,阿斯巴拉基尼尔)
- 随机森林模型实现了100%的预测准确度.
结论:
- 这项研究揭示了UC的代谢概况.
- 已识别的血清代谢物作为UC疾病程度的宝贵生物标志物.
- 代谢物可以预测UC发生和进展,支持临床应用.
更多相关视频
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
12.7K
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
8.2K
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
306
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
306
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
